GSK3B and neoplasm: In addition, CDH17 knockdown increased P53 expression; a possible mechanism would be that CDH17 knockdown leads to reduced GSK-3β phosphorylation, which in turn activates p53-dependent apoptosis and antagonizes tumor growth [28].